Evidence map›Paper›PMID 26255181›Full record

ArticleMolecular neurobiology2016

Cobalt Protoporphyrin Upregulates Cyclooxygenase-2 Expression Through a Heme Oxygenase-Independent Mechanism.

Hsiao-Yun Lin, Chon-Haw Tsai, Chingju Lin, Wei-Lan Yeh, Cheng-Fang Tsai, Pei-Chun Chang, Ling-Hsuan Wu, Dah-Yuu Lu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. SDS3 regulates microglial inflammation by modulating the expression of the upstream kinase ASK1 in the p38 MAPK signaling pathway.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hsiao-Yun LinGraduate Institute of Neural and Cognitive Sciences, China Medical University, No. 91 Hsueh-Shih Road, Taichung, Taiwan.
Chon-Haw TsaiGraduate Institute of Neural and Cognitive Sciences, China Medical University, No. 91 Hsueh-Shih Road, Taichung, Taiwan.
Chingju LinDepartment of Physiology, School of Medicine, China Medical University, Taichung, Taiwan.
Wei-Lan YehDepartment of Cell and Tissue Engineering, Changhua Christian Hospital, Changhua, Taiwan.
Cheng-Fang TsaiDepartment of Biotechnology, Asia University, Taichung, Taiwan.
Pei-Chun ChangDepartment of Bioinformatics, Asia University, Taichung, Taiwan.
Ling-Hsuan WuGraduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan.
Dah-Yuu LuGraduate Institute of Neural and Cognitive Sciences, China Medical University, No. 91 Hsueh-Shih Road, Taichung, Taiwan. dahyuu@mail.cmu.edu.tw.
China Medical University · TWAsia University · TWChina Medical University Hospital · TWChanghua Christian Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cobalt protoporphyrin (CoPP) is a potent HO-1 inducer and generally known to be an antioxidant in various cell types. Little is known about the CoPP-induced cyclooxygenase-2 (COX-2) expression and its downstream signaling in microglial cells. In current study, CoPP caused concentration- and time-dependent increases in COX-2 expression in microglial cells. Furthermore, activation of apoptosis signal-regulating kinase (ASK) 1/MAP kinase involved in CoPP-induced COX-2 expression in microglia. CoPP also induced P2X7 receptor activation, and treatment of P2X7 inhibitors effectively reduced CoPP-induced COX-2 expression. Protein inhibitor of activated STAT (PIAS) 1 is reported to be involved in modulating anti-inflammatory response through negative regulation of transcription factors. Interestingly, treatment with CoPP markedly induced PIAS1 degradation which is regulated by PI3K, Akt, and glycogen synthase kinase 3α/β (GSK3α/β) signaling pathways. These results suggest that CoPP induces COX-2 expression through activating P2X7 receptors and ASK1/MAP kinases as well as PIAS1 degradation signaling pathways. Our study provides a new insight into the regulatory effect of CoPP on neuroinflammation in microglial cells.

Indexed as

AnimalsCell LineCyclooxygenase 2Down-RegulationGlycogen Synthase Kinase 3 betaHeme Oxygenase (Decyclizing)MAP Kinase Kinase Kinase 5MiceMicrogliaModels, BiologicalPhosphatidylinositol 3-KinasesProtein Inhibitors of Activated STATProto-Oncogene Proteins c-aktProtoporphyrinsReceptors, Purinergic P2X7Signal TransductioncobaltiprotoporphyrinCyclooxygenase 2Glycogen Synthase Kinase 3 betaHeme Oxygenase (Decyclizing)Map3k5 protein, mouseMAP Kinase Kinase Kinase 5Phosphatidylinositol 3-KinasesPias1 protein, mouseProtein Inhibitors of Activated STATProto-Oncogene Proteins c-aktProtoporphyrinsReceptors, Purinergic P2X7CoPPCOX-2HO-1MicrogliaNeuroinflammation

Identifiers

PMID26255181
OpenAlexW2188608938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.